Breakthrough cancer pain: review and calls to action to improve its management
Por:
Camps Herrero, C, Batista, N, Diaz Fernandez, N, Escobar Alvarez, Y, Gonzalo Gomez, A, Isla Casado, D, Salud, A, Terrasa Pons, J and Guillem Porta, V
Publicada:
1 ago 2020
Ahead of Print:
1 ene 2020
Resumen:
In this paper, we review the current state of breakthrough cancer pain (BTcP) management. BTcP is a heterogeneous condition and a global problem for cancer patients. It is often managed suboptimally, which results in a negative outcome for patients, healthcare providers, and healthcare systems. Several barriers to the appropriate management of BTcP have been identified. These include, among others, an incomplete definition of BTcP, poor training of healthcare providers and patients alike, a lack of a multidisciplinary approach and the absence of specific protocols and tools. We provide some actions to help physicians and patients improve their approach to BTcP, including specific training, the design of easy-to-use tools for BTcP identification and assessment (such as checklists and pocket-sized cards), individualized treatment, and the use of multidisciplinary teams.
Filiaciones:
Camps Herrero, C:
Univ Valencia CIBERONC, Hosp Gen Valencia, Dept Med, Serv Oncol Med, Valencia, Spain
Batista, N:
Hosp Univ Canarias, Serv Oncol Med, Santa Cruz De Tenerife, Spain
:
Hosp Univ San Juan Alicante, Serv Oncol Med, Alicante, Spain
Escobar Alvarez, Y:
Hosp Gregorio Maranon, Serv Oncol Med, Madrid, Spain
Gonzalo Gomez, A:
Agilent Technol, Madrid, Spain
Isla Casado, D:
Hosp Clin Univ Lozano Blesa, Serv Oncol Med, Zaragoza, Spain
Salud, A:
Hosp Arnau de Vilanova Lleida, Serv Oncol Med, Lleida, Spain
Terrasa Pons, J:
Hosp Univ Son Espases, Serv Oncol Med, Palma De Mallorca, Spain
Guillem Porta, V:
Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain
|